Dr. Ameer E. Hassan is a triple board-certified neurologist who specializes in Stroke, Neurocritical care and Endovascular Surgical Neuroradiology. Dr. Hassan is head of the Neuroscience Department and an Associate Professor of Neurology and Radiology at the University of Texas, School of Health Sciences. He serves as the Director of Endovascular Surgical Neuroradiology and Clinical Neuroscience Research at the Valley Baptist Brain and Spine Network in the Valley Baptist Medical Center. Dr. Hassan received his medical degree from University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine in Stratford, NJ and completed his Residency in Neurology at the University Hospital, Newark, NJ. He then completed a Fellowship in Stroke and Neurocritical Care as well as a Fellowship in Endovascular Surgical Neuroradiology at the University of Minnesota, Minneapolis, MN. Dr. Hassan is known and recognized for his research in stroke, advanced imaging, antiplatelet use, advanced aneurysm treatment and carotid stenting. He has published over 100 papers and book chapters, and is currently the Principal Investigator of seven clinical trials. Dr. Hassan is the Chair of the American Academy of Neurology Endovascular Section. He is the current chair of the South Texas Trauma Advisory Council –V Stroke Subcommittee. He is a board member of the Society of Vascular and Interventional Neurology (SVIN) and the American Heart/American Stroke Association – Southwest Affiliate.
Chethan P. Venkatasubba
Mini CV em breve
I am an assistant professor in the departments of neurology, neurosurgery, and medical ethics, division of neurocritical care, at Baylor College of Medicine in Houston, TX. My clinical training includes a neurology residency at the University of Texas, Southwestern Medical School, neurocritical care fellowship at Johns Hopkins University, and sub-fellowships at Cambridge, and Toronto Universities. My main interests focus on the critical care management of acutely brain-injured patients, and the ethical considerations that pertain to their care. I have authored/co-authored over 60 peer-reviewed manuscripts in the areas of critical care, neurology, neurosurgery, stroke, and medical ethics.
Head of ICU.
Clinica Universidad de Los Andes, Santiago, Chile.
Coordinator of Neurocritical division of Chilean Society of Intensive Care (Sociedad Chilena de Medicina Intensiva).
Professor Geert Meyfroidt graduated as a MD in 1996, has a board certification in anesthesiology and intensive care medicine, and is clinically active at the Department of Intensive Care Medicine of the University Hospitals Leuven, and as Associate Professor of Medicine at the University of Leuven. In 2010, he finished his PhD, entitled, “Computerized data management in the intensive care unit: predictive modeling, time series analysis, and opportunities for support of care”. He receives research funding from the Flemish government (Research Foundation – Flanders (FWO), as Senior Clinical Researcher (1843113N)) and from the KU Leuven. Neuro-intensive care is his main research field, with a special interest in data mining and mathematical modeling for knowledge discovery, early warning systems and outcome prediction. He is involved in the foundation of multicenter patient databases. Other research projects include computerized decision support systems, tight blood glucose control and mathematical characteristics of the blood glucose signal, sedation and delirium in critically ill patients, and prediction of acute kidney injury in critically ill patients. He is author and co-author of more than 55 PubMed cited papers and a regular speaker at national and international conferences. Professor Meyfroidt was elected country representative for Belgium at the European Society of Intensive Care Medicine (ESICM)(2012-2015), is now active in the Neuro-Intensive Care section of ESICM, and has been serving as council member of the Belgian Society of Intensive Care Medicine (SIZ) since 2013.
Dr. Sung is the director of the division of Neurocritical Care and Stroke at the University of Southern California (USC). He received his medical degree from the University of Minnesota and was trained at the University of Maryland and at the Johns Hopkins Hospital. At Johns Hopkins, he received his first faculty appointment and also completed a Masters in Public Health in Epidemiology.
He is a founding member and past-president of the international Neurocritical Care Society (with members from over 50 different countries). He also helped start two other professional societies: the Western States Stroke Consortium, and the L.A. Stroke Society and has had leadership positions at the American Heart Association, the National Stroke Association and the American Academy of Neurology. He has had numerous papers and chapters published in a variety of journals and books and was the Associate Editor for the journal Neurocritical Care and has also been a reviewer for over 15 other journals. He has also been an invited consultant for the NIH and the FDA.
His current research interests are in the areas of measuring and changing outcomes of stroke and TBI with neurocritical care, hypothermia, intracranial pressure and cerebral reperfusion. He is also now leading an effort to standardize the determination of brain death throughout the world.
Dr. Guilherme Dabus is the Director of the Fellowship Program in Interventional Neuroradiology/ Neuroendovascular Surgery at the Miami Cardiac and Vascular Institute and Baptist Neuroscience Institute and also serves as Clinical Professor at the Herbert Wertheim College of Medicine of Florida International University. Before joining Baptist Health, Dr. Dabus served as Assistant Professor of Radiology and Neurological Surgery at Feinberg School of Medicine of Northwestern University and as the Assistant Director of the Northwestern Neuroendovascular Program and Director of Neuroangiography at Northwestern Memorial Hospital in Chicago.
After finishing his studies in Brazil, Dr Dabus moved to the US where he completed a Neuroradiology fellowship at Northwestern University in Chicago, followed by Interventional Neuroradiology/ Neurointerventional Surgery fellowships at Mallinckrodt Institute of Radiology - Washington University in St. Louis and at Massachusetts General Hospital – Harvard Medical School in Boston.
He has over one hundred publications including peer-reviewed manuscripts, invited review articles and book chapters. Dr. Dabus is an expert in the endovascular treatment of brain aneurysms, stroke and vascular malformations. He is an active lecturer, physician proctor and serves as a reviewer and member for several scientific journals and societies. He is a board member of the Society of NeuroInterventional Surgery (SNIS) and the chair of the 2018 SNIS Annual Meeting.
Gretchen M. Brophy
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS is Professor of Pharmacotherapy & Outcomes Sciences and Neurosurgery at Virginia Commonwealth University (VCU) School of Pharmacy, Medical College of Virginia Campus, in Richmond. She is also a Neurocritical Care Clinical Pharmacist at VCU Health. Dr. Brophy received her PharmD from the University of Arizona, College of Pharmacy in Tucson and her postgraduate training includes residencies in Critical Care and Pharmacy Practice at the University of Kentucky Medical Center in Lexington. She is currently the President of the Neurocritical Care Society. Dr. Brophy’s research interests include effective treatments strategies for traumatic brain injury, brain injury biomarkers, neurocritical care, hemostasis, stroke, sedation and status epilepticus. She is an investigator for the National Institutes of Health, U.S. Department of Defense and industry-funded studies. An invited speaker at national and international conferences, she publishes in the area of neurocritical care.
After his doctoral thesis at the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig (Supervisor: Prof. Dr. D. Yves von Cramon) Dr. Huttner received his specialty training 2003-2009 at the Departments of Neurology, Heidelberg, Germany (Head: Prof. Dr. Dr. h.c. W. Hacke) and Erlangen-Nuremberg, Germany (Head: Prof. Dr. Dr. h.c. S. Schwab). In 2008 Dr. Huttner became lecturer after his first professorial thesis in Experimental Neurology. After his Neurology Board Exam in 2010 and a second professorial thesis in Clinical Neurology he progressed to senior consultant/attending at the University Hospital in Erlangen, Germany. In 2013 Dr. Huttner sub-specialized in neurocritical care and geriatric Neurology. After a research stay at the Karolinska Institute in Stockholm, Sweden, (Department of Cell and Molecular Biology; Lab of Prof. Jonas Frisén) he received the Karolinska Neuroscience Doctoral Degree (PhD) in 2016. Since 2014 Dr. Huttner is associate professor and leading senior physician at the Department of Neurology at the University Hospital in Erlangen, Germany. Dr. Huttner´s main interest is improving stroke therapy and neurocritical care and developing new neuroprotective treatment strategies. He has authored more than 140 peer-reviewed articles. The lab of Hagen B. Huttner covers research of neurovascular diseases and consists of a clinical and an experimental section. Clinical research mainly relates to acute and long-term management of patients with severe ischemic stroke and intracranial hemorrhages. The experimental lab performs studies on neuroprotection and neurogenesis after stroke.
Ivan Rocha Ferreira da Silva
MD, PhD é professor assistente e neurointensivista no departamento de Neurological Sciences da Rush University (Chicago, IL). Ele possui titulo de especialista em Neurologia (ABN), Medicina Intensiva (AMIB) e Neurocritical Care (UCNS). Ele tem como foco de pesquisa em neuroinfeccao, incluindo arboviroses e encefalites. Ele tambem participou de equipe de suporte neurologico agudo para os Jogos Olimpicos 2016.
J Claude Hemphill
Dr. Claude Hemphill is Professor of Neurology and Neurological Surgery at the University of California, San Francisco and Chief of Neurology and Director of Neurocritical Care at Zuckerberg San Francisco General Hospital. His research focuses on advanced neuromonitoring and management of intracerebral hemorrhage. He is a founding director and Past-President of the Neurocritical Care Society and is a member of the editorial board of Neurocritical Care. His work has been funded by the National Institutes of Health to study intracerebral hemorrhage and conduct clinical trials for various neuroemergencies such as traumatic brain injury, status epilepticus, and stroke. He also served as chair of the writing group for the 2015 American Heart Association/American Stroke Association Guidelines for the Management of Spontaneous Intracerebral Hemorrhage.
Dr. Jan Claassen is an Associate Professor in the Department of Neurology at Columbia University College of Physicians and Surgeons. He received a degree in medicine and a Ph.D in neurophysiology studying evoked potentials after traumatic brain injury from the University of Hamburg. He underwent post-doctoral research training and clinical training in neurology, electrophysiology, and neurocritical care at Columbia University, NY. His research characterizes physiologic changes following acute brain injury, focusing on novel treatment approaches to potentially improve patient outcomes. Dr. Claassen’s group has focused on the use of innovative brain monitoring techniques including continuous EEG monitoring with a particular focus on studying recovery of consciousness. Dr. Claassen has been intimately involved with national and international guideline development for patients with acute brain injury. He is on the Editorial board of Annals of Neurology and Neurocritical Care. He has published over 200 peer-reviewed articles and many book chapters. He is the co-editor of the 5th edition of Plum and Posner's Diagnosis and Treatment of Stupor and Coma and the 3rd Edition of Seizures in Critical Care - A Guide to Diagnosis and Therapeutics
Jorge H. Mejía
Mini CV em breve
Mini CV em breve
María Julieta Russo, M.D., is a behavioral neurologist and cognitive neuroscientist whose work focuses on identifying and implementing better methods for improving language, memory, thinking skills, and learning in individuals with amnesia, Alzheimer’s disease and related disorders, and other acquired brain conditions such as stroke or brain injury. Expertise: Behavioral Disorder, Cognitive Disorders , Memory Disorders, Neurology, Speech and Language Impairments FLENI Institute, Buenos Aires, Argentina.
Jefe de la UCI. Hospital Eugenio Espejo, Quito, Ecuador. Presidente, Latin American Brain Injury Consortioum (LABIC). Coordinador, Red Latinoamericana Investigación Medicina Intensiva de Altura (RELAMI). Miembro de Latin American Intensive Care Network (LIVEN). Profesor, Escuela de Medicina de la Universidad Internacional del Ecuador (UIDE).
Mary Kay Bader
Mini CV em breve
Panayiotis N. Varelas, MD, PhD, FNCS was born in Athens, Greece, attended the prestigious Lycee Leonin Private School in Athens and received his medical degree from the University of Athens Medical School in 1983. He did Anesthesiology and Neurology residency in Athens and repeated Neurology residency at Yale University School of Medicine in New Haven, CT. He then completed a Neuro-Critical Care Fellowship at the Johns Hopkins Hospital in Baltimore, MD in 2000.
After completing his fellowship he directed the Neurosciences Intensive Care Unit at the Medical College of Wisconsin for 5 years, before joining Henry Ford Health System in 2005.
Dr. Varelas is currently the Division Head of the Neurosciences Critical Care Service at Henry Ford Health System, the Director of the Neurosciences Intensive Care Unit at Henry Ford Hospital in Detroit, MI and is also Professor of Clinical Neurology at Wayne State University in Detroit, MI.
Dr. Varelas has published more than 95 peer reviewed journal articles, 1 book (currently in 3d Edition), more than 27 book chapters, and more than 135 abstracts in scientific meetings. He is participating in several federal or industry research grants and is an ad hoc reviewer for many journals, including Critical Care Medicine, Neurocritical Care, Stroke, Neurosurgery and Neurology. He belongs to the Editorial Board of the Neurocritical Care Society’s official journal, Neurocritical Care.
Dr Varelas is currently a member of the Board of Directors of the Neurocritical Care Society, and is also a member of the Society of Critical Care Medicine and the American Academy of Neurology (where he has served as Chairman in the Critical Care and Emergency Neurology Section). Dr Varelas is also the past Chairman of the Advisory Board of Gift of Life of Michigan, the Organ Transplant & Procurement Organization of the State of Michigan.
Raul Gomes Nogueira
Mini CV em breve
Mini CV em breve
Dr. Wade Smith is Chief of the UCSF Neurovascular Division within of the Department of Neurology at UCSF. He received his medical degree and a doctorate in neurophysiology from the University of Washington, and came to the San Francisco Bay Area in 1989 for residency training in UCSF’s Department of Neurology. He later completed a fellowship in critical care medicine at UCSF, where he helped establish the Neurovascular Service and the UCSF Stroke Service. He assumed the directorship of this division in 2002.
The UCSF Department of Neurology is the largest NIH-supported department in the world. One of its many focuses is stroke and neurovascular disease. This focus includes the prevention, acute treatment and recovery from stroke from basic science to the application of treatments to patients by engaging actively in research and innovative clinical care. Dr. Smith is a neurointensivist: a neurologist trained in both critical care and neurology. He directs the UCSF Neurological Intensive Care unit, a 29-bed ICU dedicated to the care and resuscitation of patients with neurological injury. Many of these patients suffer from neurovascular diseases.
In addition to the clinical innovations Dr. Smith has created at UCSF, his research career has brought major advances to stroke patients. He was principal investigator of 3 clinical trials that led to the first medical devices cleared by the FDA to re-open cerebral blood vessels during acute ischemic stroke. This innovation has changed the way stroke is treated world-wide. In addition, he has focused on innovative methods to image the brain during stroke, and has focused on developing novel medical devices that detect vasospasm, brain swelling and brain concussion.
Dr. Smith co-founded the Neurocritical Care Society in the US, is now Secretary of the Society, and has been the leader in developing Emergency Neurological Life Support (ENLS).
Mini CV em breve